# Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.

> **NCT06305390** · PHASE2 · RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 167 (estimated)

## Conditions studied

- Clinical Suspicion of Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** PET/MRI

## Key facts

- **NCT ID:** NCT06305390
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-04
- **Primary completion:** 2026-03-24
- **Final completion:** 2027-04
- **Target enrollment:** 167 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06305390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06305390, "Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06305390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*